Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase Inhibitors

BACKGROUND: When treating patients with advanced non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors and chemotherapy, intercalated schedule with time separation between the two classes of drugs should avoid their mutual antagonism. In a survey of published trials, we focus on relatio...

Full description

Saved in:
Bibliographic Details
Published in:Radiol Oncol
Main Authors: Zwitter, Matjaz, Rossi, Antonio, Di Maio, Massimo, Perme, Maja Pohar, Lopes, Gilberto
Format: Artigo
Language:Inglês
Published: De Gruyter Open 2017
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5611988/
https://ncbi.nlm.nih.gov/pubmed/28959160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2017-0029
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items